Yan Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yan Xu has a total of 255 co-authors. Here are the top co-authors by number of shared publications:
Chen Guan
Department of Nephrology The Affiliated Hospital of Qingdao University Qingdao China
39 shared publicationsLingyu Xu
35 shared publicationsChenyu Li
Department of Nephrology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao, Shandong Province, China
34 shared publicationsLong Zhao
32 shared publicationsChengyu Yang
Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China
28 shared publicationsLin Che
28 shared publications
Latest Publications
- 10 November 2026
- Published by Wiley in Advanced Functional Materials
Lipopolysaccharide‐Triggered Self‐Assembling Peptide Nanotraps for Coordinated Capture‐Killing‐Endotoxin Neutralization in Complicated Urinary Tract Infection
Complicated urinary tract infections (cUTIs) caused by uropathogenic E. coli (UPEC) remain difficult to treat because multidrug resistance and continuous urinary washout jointly limit antibacterial efficacy and local drug retention. Here, a lipopolysaccharide (LPS)‐responsive supramolecular peptide conjugate, PpIX‐GFFVLK‐HWKAVNWLKPWT (PFFH), is developed to address this delivery–retention trade‐off through pathogen‐triggered structural adaptation. PFFH integrates an E. coli LPS‐binding motif, a β‐sheet‐forming self‐assembly segment, and a PpIX sonosensitizer. It remains dispersed during delivery but transforms into peribacterial nanofibrous networks upon LPS recognition, promoting bacterial trapping and positioning PpIX near the bacterial interface for localized sonodynamic ROS activity. PFFH retains LPS‐responsive assembly and antibacterial activity under urine‐mimicking conditions and effectively kills reference and multidrug‐resistant UPEC. The same LPS‐binding motif also sequesters bacteriolysis‐derived endotoxin and attenuates inflammatory activation. In a mouse cUTI model, PFFH shows prolonged retention at infected urinary sites, reduces bacterial burdens, and alleviates inflammatory injury. Thus, PFFH extends LPS‐triggered structural adaptation beyond bacterial trapping to resolve the delivery–retention trade‐off in cUTIs, while coupling peribacterial sonodynamic activity with endotoxin regulation in a single molecular platform, thereby establishing a disease‐adapted supramolecular strategy for drug‐resistant cUTIs.
- 10 November 2026
- Published by Wiley in Advanced Functional Materials
Lipopolysaccharide‐Triggered Self‐Assembling Peptide Nanotraps for Coordinated Capture‐Killing‐Endotoxin Neutralization in Complicated Urinary Tract Infection
Complicated urinary tract infections (cUTIs) caused by uropathogenic E. coli (UPEC) remain difficult to treat because multidrug resistance and continuous urinary washout jointly limit antibacterial efficacy and local drug retention. Here, a lipopolysaccharide (LPS)‐responsive supramolecular peptide conjugate, PpIX‐GFFVLK‐HWKAVNWLKPWT (PFFH), is developed to address this delivery–retention trade‐off through pathogen‐triggered structural adaptation. PFFH integrates an E. coli LPS‐binding motif, a β‐sheet‐forming self‐assembly segment, and a PpIX sonosensitizer. It remains dispersed during delivery but transforms into peribacterial nanofibrous networks upon LPS recognition, promoting bacterial trapping and positioning PpIX near the bacterial interface for localized sonodynamic ROS activity. PFFH retains LPS‐responsive assembly and antibacterial activity under urine‐mimicking conditions and effectively kills reference and multidrug‐resistant UPEC. The same LPS‐binding motif also sequesters bacteriolysis‐derived endotoxin and attenuates inflammatory activation. In a mouse cUTI model, PFFH shows prolonged retention at infected urinary sites, reduces bacterial burdens, and alleviates inflammatory injury. Thus, PFFH extends LPS‐triggered structural adaptation beyond bacterial trapping to resolve the delivery–retention trade‐off in cUTIs, while coupling peribacterial sonodynamic activity with endotoxin regulation in a single molecular platform, thereby establishing a disease‐adapted supramolecular strategy for drug‐resistant cUTIs.
- Open Access
- 3 November 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 2009688
Case Report: Serial 4D-CT evolution from focal leaflet thickening to multileaflet HALT after transcatheter aortic valve replacement in a hemodialysis patient
Background: Electrocardiographically gated multiphase cardiac computed tomography (4D-CT) is the reference imaging technique for detecting hypoattenuated leaflet thickening (HALT) and assessing associated leaflet-motion abnormalities after transcatheter aortic valve replacement (TAVR). The significance of an isolated abnormality detected during the first postoperative week remains uncertain. Case description: A 51-year-old woman receiving maintenance hemodialysis for 13 years underwent transfemoral TAVR with a 23-mm Edwards SAPIEN 3 valve. A visible prosthetic waist was treated by balloon post-dilatation, reducing the invasive transvalvular gradient from 60 to 1 mmHg. Routine postoperative day-7 ECG-gated 4D-CT, reconstructed in 10 phases across the cardiac cycle, showed focal noncoronary cusp thickening measuring 2.5 mm on short-axis and 2.4 mm on long-axis images, with preserved leaflet motion. The immediate post-TAVR mean gradient was 4 mmHg; the nearest early follow-up examination on postoperative day 6 showed a mean gradient of 11 mmHg and a Doppler velocity index of 0.50. Serial echocardiography subsequently showed progressive hemodynamic deterioration. At approximately 7.5 months, limited-phase ECG-gated CT comprising paired systolic and diastolic reconstructions demonstrated multileaflet HALT with predominant right coronary cusp involvement. The abnormal tissue measured approximately 85 HU, extended 14.7 mm longitudinally, reached a maximal thickness of 3.1 mm, and was associated with an estimated 75% reduction in systolic leaflet excursion. The contemporaneous mean gradient was 25 mmHg and increased to 30 mmHg approximately 3 weeks later. Conclusion: This case documents a temporal sequence from an early focal leaflet abnormality with preserved motion to multileaflet HALT, marked motion restriction, and prosthetic valve hemodynamic deterioration. The sequence supports integrated longitudinal assessment but does not establish that the early focal lesion predicted or caused the subsequent HALT.
- 3 November 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 2009688
Open AccessCase Report: Serial 4D-CT evolution from focal leaflet thickening to multileaflet HALT after transcatheter aortic valve replacement in a hemodialysis patient
Background: Electrocardiographically gated multiphase cardiac computed tomography (4D-CT) is the reference imaging technique for detecting hypoattenuated leaflet thickening (HALT) and assessing associated leaflet-motion abnormalities after transcatheter aortic valve replacement (TAVR). The significance of an isolated abnormality detected during the first postoperative week remains uncertain. Case description: A 51-year-old woman receiving maintenance hemodialysis for 13 years underwent transfemoral TAVR with a 23-mm Edwards SAPIEN 3 valve. A visible prosthetic waist was treated by balloon post-dilatation, reducing the invasive transvalvular gradient from 60 to 1 mmHg. Routine postoperative day-7 ECG-gated 4D-CT, reconstructed in 10 phases across the cardiac cycle, showed focal noncoronary cusp thickening measuring 2.5 mm on short-axis and 2.4 mm on long-axis images, with preserved leaflet motion. The immediate post-TAVR mean gradient was 4 mmHg; the nearest early follow-up examination on postoperative day 6 showed a mean gradient of 11 mmHg and a Doppler velocity index of 0.50. Serial echocardiography subsequently showed progressive hemodynamic deterioration. At approximately 7.5 months, limited-phase ECG-gated CT comprising paired systolic and diastolic reconstructions demonstrated multileaflet HALT with predominant right coronary cusp involvement. The abnormal tissue measured approximately 85 HU, extended 14.7 mm longitudinally, reached a maximal thickness of 3.1 mm, and was associated with an estimated 75% reduction in systolic leaflet excursion. The contemporaneous mean gradient was 25 mmHg and increased to 30 mmHg approximately 3 weeks later. Conclusion: This case documents a temporal sequence from an early focal leaflet abnormality with preserved motion to multileaflet HALT, marked motion restriction, and prosthetic valve hemodynamic deterioration. The sequence supports integrated longitudinal assessment but does not establish that the early focal lesion predicted or caused the subsequent HALT.
- Open Access
- 11 July 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 252, 118244
Cartilage oligomeric matrix protein inhibits CKD-associated vascular calcification by suppressing PANoptosis in VSMCs via the AT1R/β-arrestin-2 axis
- 11 July 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 252, 118244
Open AccessCartilage oligomeric matrix protein inhibits CKD-associated vascular calcification by suppressing PANoptosis in VSMCs via the AT1R/β-arrestin-2 axis
- Open Access
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1739677
Activation of BK channels ameliorates cardiac injury Via NFκB-NLRP3 signaling in angiotensin II-induced hypertension mouse model
Background: Hypertension-induced cardiac fibrosis leads to heart failure. Large-conductance calcium-activated potassium (BK) channels regulate vascular tone, and their activation may mitigate fibrosis. This study explores the impact of BK channel activation on angiotensin II (Ang II)-induced hypertension and cardiac fibrosis and its effects on nuclear factor-kappa B (NFκB) signaling. Methods: Male C57BL/6 J mice were infused with Ang II for 4 weeks to induce hypertension and cardiac fibrosis. The BK channel activator BMS-191011 was administered via intraperitoneal injection. Cardiac tissue was analyzed using histology, Western blotting and qPCR. Single channel recordings were used to analyze the activation of BKα channels. A dihydroethidium (DHE) Assay was used to detect superoxide (ROS) production. Superoxide Dismutase (SOD) was measured using a colorimetric activity kit. In vitro , macrophages (RAW 264.7) were stimulated with Ang II, to detect NFκB activation and macrophage polarization. Results: The expression of BKα mRNA and protein abundance was decreased while markers of cardiac fibrosis (fibronectin, vimentin, αSMA and TGF-β) and ROS production were increased in the hearts of Ang II-induced hypertensive mice. In addition, macrophage infiltration was significantly increased along with inflammatory cytokines IFNγ, IL-6, IL-4, IL-10 and TNFα. The BK channel opener, BMS-191011, significantly reduced hypertension, cardiac fibrosis, and ROS production, but restored SOD in the hearts of Ang II-treated mice. In cultured macrophages, we found that Ang II increased inflammatory cytokines through NFκB-NLRP3-caspase-1 signaling. After Ang II treatment, BK channel activation inhibited NFκB, NLRP3 and caspase-1 expression. BK channel activation also suppressed NFκB-NLRP3 signaling, leading to reduced ROS accumulation and restored SOD activity. Conclusion: BK channel activation reduces Ang II-induced hypertension and cardiac fibrosis by modulating oxidative stress, inflammation and macrophage polarization through the NFκB-NLRP3 pathway. These findings implicate BK channel activators as a potential novel therapeutic strategy for hypertensive cardiomyopathy.
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1739677
Open AccessActivation of BK channels ameliorates cardiac injury Via NFκB-NLRP3 signaling in angiotensin II-induced hypertension mouse model
Background: Hypertension-induced cardiac fibrosis leads to heart failure. Large-conductance calcium-activated potassium (BK) channels regulate vascular tone, and their activation may mitigate fibrosis. This study explores the impact of BK channel activation on angiotensin II (Ang II)-induced hypertension and cardiac fibrosis and its effects on nuclear factor-kappa B (NFκB) signaling. Methods: Male C57BL/6 J mice were infused with Ang II for 4 weeks to induce hypertension and cardiac fibrosis. The BK channel activator BMS-191011 was administered via intraperitoneal injection. Cardiac tissue was analyzed using histology, Western blotting and qPCR. Single channel recordings were used to analyze the activation of BKα channels. A dihydroethidium (DHE) Assay was used to detect superoxide (ROS) production. Superoxide Dismutase (SOD) was measured using a colorimetric activity kit. In vitro , macrophages (RAW 264.7) were stimulated with Ang II, to detect NFκB activation and macrophage polarization. Results: The expression of BKα mRNA and protein abundance was decreased while markers of cardiac fibrosis (fibronectin, vimentin, αSMA and TGF-β) and ROS production were increased in the hearts of Ang II-induced hypertensive mice. In addition, macrophage infiltration was significantly increased along with inflammatory cytokines IFNγ, IL-6, IL-4, IL-10 and TNFα. The BK channel opener, BMS-191011, significantly reduced hypertension, cardiac fibrosis, and ROS production, but restored SOD in the hearts of Ang II-treated mice. In cultured macrophages, we found that Ang II increased inflammatory cytokines through NFκB-NLRP3-caspase-1 signaling. After Ang II treatment, BK channel activation inhibited NFκB, NLRP3 and caspase-1 expression. BK channel activation also suppressed NFκB-NLRP3 signaling, leading to reduced ROS accumulation and restored SOD activity. Conclusion: BK channel activation reduces Ang II-induced hypertension and cardiac fibrosis by modulating oxidative stress, inflammation and macrophage polarization through the NFκB-NLRP3 pathway. These findings implicate BK channel activators as a potential novel therapeutic strategy for hypertensive cardiomyopathy.
- Open Access
- 12 May 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
Development and external validation of an interpretable early prediction model for acute kidney injury using TabPFN and routine admission data: a retrospective cohort study
Background: Acute kidney injury (AKI) is a common and serious complication among hospitalized patients, and early risk stratification remains challenging due to heterogeneous clinical data and limited interpretability of existing prediction models. Foundation models designed for tabular data may enable accurate prediction while preserving interpretability, but their application in early AKI risk assessment has not been fully explored. Objective: To develop and externally validate an interpretable early prediction model for AKI using the Tabular Prior-data Fitted Network (TabPFN) based on routinely available admission data. Methods: In this retrospective cohort study, predictors were restricted to clinical variables recorded within the 24 h prior to hospital admission, and this temporal definition was applied consistently across both the internal cohort and the external MIMIC-IV validation dataset. Time zero was defined as the admission time. Baseline serum creatinine (SCr) was defined as the first creatinine measurement at admission. The primary outcome was in-hospital AKI, defined according to KDIGO SCr criteria as a subsequent rise in creatinine relative to this admission baseline at any time during the index hospitalization. A total of 44,324 patients were included in the development cohort. TabPFN was trained on a stratified subsample and evaluated on a held-out internal test set, and benchmarked against seven conventional machine-learning models. Missing data were handled using multivariate imputation, and model interpretation was performed using SHAP-based attribution analyses. External validation was conducted in the MIMIC-IV database following predefined inclusion criteria and feature harmonization. Results: In the internal test set, TabPFN achieved an AUROC of 0.953, outperforming comparator models. External validation demonstrated robust discrimination with an AUROC of 0.859. Calibration analyses indicated good agreement between predicted and observed risks. Attribution analyses identified baseline renal function and acute illness markers as major contributors to model-attributed AKI risk, with heterogeneous association patterns across patient subgroups. Conclusions: Using routinely available pre-admission data, TabPFN enabled accurate early prediction of in-hospital AKI and provided interpretable risk attribution patterns. These findings suggest potential utility for early risk stratification; however, results are observational and hypothesis-generating, and prospective validation is required before clinical deployment.
- 12 May 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 26 (1)
Open AccessDevelopment and external validation of an interpretable early prediction model for acute kidney injury using TabPFN and routine admission data: a retrospective cohort study
Background: Acute kidney injury (AKI) is a common and serious complication among hospitalized patients, and early risk stratification remains challenging due to heterogeneous clinical data and limited interpretability of existing prediction models. Foundation models designed for tabular data may enable accurate prediction while preserving interpretability, but their application in early AKI risk assessment has not been fully explored. Objective: To develop and externally validate an interpretable early prediction model for AKI using the Tabular Prior-data Fitted Network (TabPFN) based on routinely available admission data. Methods: In this retrospective cohort study, predictors were restricted to clinical variables recorded within the 24 h prior to hospital admission, and this temporal definition was applied consistently across both the internal cohort and the external MIMIC-IV validation dataset. Time zero was defined as the admission time. Baseline serum creatinine (SCr) was defined as the first creatinine measurement at admission. The primary outcome was in-hospital AKI, defined according to KDIGO SCr criteria as a subsequent rise in creatinine relative to this admission baseline at any time during the index hospitalization. A total of 44,324 patients were included in the development cohort. TabPFN was trained on a stratified subsample and evaluated on a held-out internal test set, and benchmarked against seven conventional machine-learning models. Missing data were handled using multivariate imputation, and model interpretation was performed using SHAP-based attribution analyses. External validation was conducted in the MIMIC-IV database following predefined inclusion criteria and feature harmonization. Results: In the internal test set, TabPFN achieved an AUROC of 0.953, outperforming comparator models. External validation demonstrated robust discrimination with an AUROC of 0.859. Calibration analyses indicated good agreement between predicted and observed risks. Attribution analyses identified baseline renal function and acute illness markers as major contributors to model-attributed AKI risk, with heterogeneous association patterns across patient subgroups. Conclusions: Using routinely available pre-admission data, TabPFN enabled accurate early prediction of in-hospital AKI and provided interpretable risk attribution patterns. These findings suggest potential utility for early risk stratification; however, results are observational and hypothesis-generating, and prospective validation is required before clinical deployment.
- 20 April 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 265, 115721
Near-Infrared-Responsive Bi2Fe4O9/rGO nanocomposite for intravesical antibacterial photodynamic therapy of urinary tract infections
- 20 April 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 265, 115721
Near-Infrared-Responsive Bi2Fe4O9/rGO nanocomposite for intravesical antibacterial photodynamic therapy of urinary tract infections
- 8 April 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (7) , e71757
Crosstalk Between Clec7a and TLR4 Immune Pathway Drives Renal Damage in a Cisplatin‐Induced Acute Kidney Injury Model
Macrophage‐associated immune responses play a critical role in acute kidney injury (AKI). Clec7a, primarily expressed on activated myeloid cells, functions as a pattern recognition receptor essential for regulating immune homeostasis. However, its specific effects and roles during AKI remain unclear. To investigate the role of Clec7a in AKI, we used a cisplatin‐induced acute kidney injury (cis‐AKI) model. We administered the Clec7a antagonist laminarin (LAM) and performed macrophage depletion. Additionally, we utilized siRNA to silence Clec7a and transferred Clec7a‐expressing primary peritoneal macrophages (PPMs) to mice to explore potential therapeutic targets. Chromatin immunoprecipitation (ChIP) assays were conducted to demonstrate the physical binding of NF‐κB/P65 to the Clec7a promoter. Our findings revealed an increase in Clec7a‐expressing macrophages in the cis‐AKI model. Blocking Clec7a signaling with LAM alleviated cisplatin‐induced renal inflammation, an effect also observed with the knockdown of Clec7a in transferred PPMs. Notably, this study shows that Clec7a activation by its agonist d‐Zymosan induces renal inflammation and up‐regulates iNOS in C57BL/6 mice. Furthermore, both TLR4 and NF‐κB inhibitors were able to antagonize LPS‐induced Clec7a expression. ChIP assays confirmed the physical binding of NF‐κB to the Clec7a promoter, indicating the regulatory effect of the TLR4/NF‐κB signaling pathway on Clec7a expression. The synergistic signaling crosstalk between Clec7a‐Syk and TLR4/NF‐κB promotes and sustains the inflammatory phenotypes of M1 macrophages, contributing to damage in AKI. These findings provide novel insights into the pivotal role of Clec7a in renal inflammation and suggest its potential as a therapeutic target for AKI.
- 8 April 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (7) , e71757
Crosstalk Between Clec7a and TLR4 Immune Pathway Drives Renal Damage in a Cisplatin‐Induced Acute Kidney Injury Model
Macrophage‐associated immune responses play a critical role in acute kidney injury (AKI). Clec7a, primarily expressed on activated myeloid cells, functions as a pattern recognition receptor essential for regulating immune homeostasis. However, its specific effects and roles during AKI remain unclear. To investigate the role of Clec7a in AKI, we used a cisplatin‐induced acute kidney injury (cis‐AKI) model. We administered the Clec7a antagonist laminarin (LAM) and performed macrophage depletion. Additionally, we utilized siRNA to silence Clec7a and transferred Clec7a‐expressing primary peritoneal macrophages (PPMs) to mice to explore potential therapeutic targets. Chromatin immunoprecipitation (ChIP) assays were conducted to demonstrate the physical binding of NF‐κB/P65 to the Clec7a promoter. Our findings revealed an increase in Clec7a‐expressing macrophages in the cis‐AKI model. Blocking Clec7a signaling with LAM alleviated cisplatin‐induced renal inflammation, an effect also observed with the knockdown of Clec7a in transferred PPMs. Notably, this study shows that Clec7a activation by its agonist d‐Zymosan induces renal inflammation and up‐regulates iNOS in C57BL/6 mice. Furthermore, both TLR4 and NF‐κB inhibitors were able to antagonize LPS‐induced Clec7a expression. ChIP assays confirmed the physical binding of NF‐κB to the Clec7a promoter, indicating the regulatory effect of the TLR4/NF‐κB signaling pathway on Clec7a expression. The synergistic signaling crosstalk between Clec7a‐Syk and TLR4/NF‐κB promotes and sustains the inflammatory phenotypes of M1 macrophages, contributing to damage in AKI. These findings provide novel insights into the pivotal role of Clec7a in renal inflammation and suggest its potential as a therapeutic target for AKI.
- Open Access
- 14 March 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 249, 117901
Endothelial Foxp1 overexpression inhibits endothelial-to-mesenchymal transition via suppressing Notch pathway activation to attenuate valvular calcification in chronic kidney disease
- 14 March 2026
- Published by Elsevier in Biochemical Pharmacology
- Vol. 249, 117901
Open AccessEndothelial Foxp1 overexpression inhibits endothelial-to-mesenchymal transition via suppressing Notch pathway activation to attenuate valvular calcification in chronic kidney disease